Evolving therapies for the treatment of chronic hepatitis B virus infection. - Wikidata - awgldk - TriplyDB

Evolving therapies for the treatment of chronic hepatitis B virus infection.

Evolving therapies for the treatment of chronic hepatitis B virus infection.

http://www.wikidata.org/entity/Q34519117

about

Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine.Treatment of chronic hepatitis B: case selection and duration of therapy.Agents in clinical development for the treatment of chronic hepatitis B.The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro.Generation of cytotoxic T cell against HBcAg using retrovirally transduced dendritic cells.

P2860

Q33206221-01CCFFDA-734B-4C19-A275-5337883C4E79 Q34619363-D07B6244-4D1B-4CF0-8EA8-F8DB519F2DA3 Q35185749-FD2FC36C-A990-44E6-9FAC-1A39183FA68E Q40012022-4396CC36-9B86-4080-80D8-F312ECB863F1 Q42085851-F75A6365-4F40-4E11-A572-2F19720F892F

P2860

Evolving therapies for the treatment of chronic hepatitis B virus infection.

http://www.wikidata.org/entity/Q34519117

description

2002 nî lūn-bûn

@nan

2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Evolving therapies for the treatment of chronic hepatitis B virus infection.

@ast

Evolving therapies for the treatment of chronic hepatitis B virus infection.

@en

Evolving therapies for the treatment of chronic hepatitis B virus infection.

@nl

type

label

Evolving therapies for the treatment of chronic hepatitis B virus infection.

@ast

Evolving therapies for the treatment of chronic hepatitis B virus infection.

@en

Evolving therapies for the treatment of chronic hepatitis B virus infection.

@nl

prefLabel

Evolving therapies for the treatment of chronic hepatitis B virus infection.

@ast

Evolving therapies for the treatment of chronic hepatitis B virus infection.

@en

Evolving therapies for the treatment of chronic hepatitis B virus infection.

@nl

P1433

Q34519117-B81252F5-441F-423A-A68B-83B5BA220A98

P1476

Q34519117-BDB2E7EC-50C7-4BBC-9B04-21FDAE4C68E5

P2093

Q34519117-133508E6-C27D-4171-954A-D5A7151097E9

Q34519117-5E510371-EB2A-47BF-930F-099EB8CBD544

Q34519117-CD002A29-1ABC-44D5-908B-DA901366E82C

P2860

Q34519117-010D5F39-14DF-43C9-8318-44B4559DE636

Q34519117-0889BD05-35F2-49F1-82C8-115B961FDCFF

Q34519117-0BB1D292-2918-42B7-9635-84754DE37FBC

Q34519117-14FDDC88-3A6F-4B28-A738-E81C7322E9A1

Q34519117-15C4AE5E-6111-4415-B8B9-A608B0BE82E6

Q34519117-198AB834-F121-4939-925E-373D7B7E496F

Q34519117-1DBA81EC-2B30-44DC-A3DC-CEE8DB1C21B6

Q34519117-1E43F665-3413-417D-AB83-92B4C7CF41E8

Q34519117-1FAECAC9-7B43-4CB3-AE25-0002C0FE0ACB

Q34519117-259DAF49-EAE3-433E-BF93-DF321FFE67A0

P304

Q34519117-07019B07-5DB4-4C7C-A6B7-92F351F4D820

P31

Q34519117-8FF705E8-D38F-45CA-99A6-74BC441C6B8F

P356

Q34519117-B3FC4C8D-645F-4999-B718-9A96573AD716

P407

Q34519117-87B64073-93FD-4DB9-A542-9C7254B677E9

P433

Q34519117-AD2362DE-4EAC-4E14-97E6-3428A839F394

P478

Q34519117-0F56FFFF-A5BC-4A19-BC54-424688846F23

P577

Q34519117-6475E33E-87E3-42C1-B65F-0A486AE37A27

P698

Q34519117-35573E7B-A363-4CF4-87BC-7EC3BB996381

P356

13543784.11.2.169

P1433

Expert Opinion on Investigational Drugs

P1476

Evolving therapies for the treatment of chronic hepatitis B virus infection.

@en

P2093

Angeline Bartholomeusz

http://www.w3.org/2001/XMLSchema#string

Stephen A Locarnini

http://www.w3.org/2001/XMLSchema#string

William Delaney

http://www.w3.org/2001/XMLSchema#string

P2860

DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state

Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues

The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus

Effect of oral administration of emtricitabine on woodchuck hepatitis virus replication in chronically infected woodchucks

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group

α-Glucosidase inhibitors as potential broad based anti-viral agents

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

Analysis of the pre-S2 N- and O-linked glycans of the M surface protein from human hepatitis B virus.

DNA prime/canarypox boost-based immunotherapy of chronic hepatitis B virus infection in a chimpanzee.

P304

169-187

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.11.2.169

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11829711

http://www.w3.org/2001/XMLSchema#string